BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2465043)

  • 21. c-fms expression in acute leukemias with complex phenotypes.
    Torrès H; Dubreuil P; Falzetti F; Courcoul MA; Lopez M; Falcinelli F; Birg F; Tabilio A; Mannoni P
    Leukemia; 1990 Oct; 4(10):673-7. PubMed ID: 2214871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of colony-stimulating factor-1 activity by monoclonal antibodies to the human CSF-1 receptor.
    Sherr CJ; Ashmun RA; Downing JR; Ohtsuka M; Quan SG; Golde DW; Roussel MF
    Blood; 1989 May; 73(7):1786-93. PubMed ID: 2540857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia.
    Biethahn S; Alves F; Wilde S; Hiddemann W; Spiekermann K
    Exp Hematol; 1999 May; 27(5):885-94. PubMed ID: 10340405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
    Valent P; Spanblöchl E; Bankl HC; Sperr WR; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler HG; Agis H; Sillaber C
    Blood; 1994 Dec; 84(12):4322-32. PubMed ID: 7527672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric analysis of membrane CD11b, CD11c and CD14 expression in acute myeloid leukaemia: relationships with monocytic subtypes and the concept of relative antigen expression.
    Scott CS; Richards SJ; Master PS; Kendall J; Limbert HJ; Roberts BE
    Eur J Haematol; 1990 Jan; 44(1):24-9. PubMed ID: 1689668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.
    Bühring HJ; Sures I; Jallal B; Weiss FU; Busch FW; Ludwig WD; Handgretinger R; Waller HD; Ullrich A
    Blood; 1995 Sep; 86(5):1916-23. PubMed ID: 7544646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The colony-stimulating factor 1 (CSF-1) receptor (c-fms proto-oncogene product) and its ligand.
    Rettenmier CW; Roussel MF; Sherr CJ
    J Cell Sci Suppl; 1988; 9():27-44. PubMed ID: 2978516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A granulocytic population with rearranged immunogenotype in chronic myelocytic leukemia blast crisis and Philadelphia-chromosome-positive acute leukemia with cross-lineage nature.
    Kita K; Shimizu N; Miwa H; Ikeda T; Nishii K; Morita N; Uchida T; Shirakawa S; Tsutani H; Nasu K
    Leukemia; 1993 Feb; 7(2):251-7. PubMed ID: 8381195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
    Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
    Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages.
    Birg F; Courcoul M; Rosnet O; Bardin F; Pébusque MJ; Marchetto S; Tabilio A; Mannoni P; Birnbaum D
    Blood; 1992 Nov; 80(10):2584-93. PubMed ID: 1384791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.
    Sherr CJ; Rettenmier CW; Sacca R; Roussel MF; Look AT; Stanley ER
    Cell; 1985 Jul; 41(3):665-76. PubMed ID: 2408759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocytes appearing repeatedly after chemotherapies had an identical rearrangement pattern of immunoglobulin with leukemic blasts in a patient with CD13+ acute lymphoblastic leukemia.
    Mizuki M; Tagawa S; Nojima J; Nakamura Y; Morita T; Yumura-Yagi K; Hara J; Kawa-Ha K; Kitani T
    Acta Haematol; 1992; 87(1-2):88-93. PubMed ID: 1350159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of myeloid-specific antigens on myeloid leukemia cells: correlations with leukemia subclasses and implications for normal myeloid differentiation.
    Ball ED; Fanger MW
    Blood; 1983 Mar; 61(3):456-63. PubMed ID: 6186318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia.
    Kurec AS; Belair P; Stefanu C; Barrett DM; Dubowy RL; Davey FR
    Cancer; 1991 Jun; 67(12):3081-6. PubMed ID: 2044051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-fms expression is a molecular marker of human acute myeloid leukemias.
    Dubreuil P; Torrès H; Courcoul MA; Birg F; Mannoni P
    Blood; 1988 Sep; 72(3):1081-5. PubMed ID: 2970873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression.
    Maniecki MB; Etzerodt A; Moestrup SK; Møller HJ; Graversen JH
    Immunobiology; 2011 Aug; 216(8):882-90. PubMed ID: 21458881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation-associated expression of two functionally distinct classes of granulocyte-macrophage colony-stimulating factor receptors by human myeloid cells.
    Cannistra SA; Koenigsmann M; DiCarlo J; Groshek P; Griffin JD
    J Biol Chem; 1990 Jul; 265(21):12656-63. PubMed ID: 2165070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential responses of CD34-positive acute myelogenous leukemic blasts to the costimulating effects of stem cell factor with GM-CSF and/or IL-3.
    Min YH; Lee ST; Lee BK; Chong SY; Lee S; Hahn JS; Ko YW
    Yonsei Med J; 1995 Mar; 36(1):26-36. PubMed ID: 7537932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.